T-Cell Therapy And Genomic Pathology, University Of Pennsylvania

T-Cell Therapy and Genomic Pathology, University of Pennsylvania

WebsEdgeMedicine

2022 Research Briefings: Carl June, University of Pennsylvania Perelman School of Medicine

National Academy of Sciences

LMP Grand Rounds SGill 8Jan2020

um-lmp UofM Laboratory Medicine and Pathology

Personalized Medicine and the Future of Pathology at Penn

Regulatory and commercialization challenges with CAR T-cell therapy

VJHemOnc – Video Journal of Hematology & HemOnc

The Expanding Role of Transfusion Medicine in Personalized Medicine and Therapeutics

We can train the immune system to kill cancer cells | Carl June | Nobel Conference

Gustavus Adolphus College

Keynote: Carl June | Therapy Gladstone-UCSF Institute of Genomic Immunology Symposium

Gladstone Institutes

Updates in CAR T Cell Therapies

National Cancer Institute

CAR-T Cell Therapy: Now and in 2030 | Laboratory Medicine and Pathology in Individualized Medicine

Applications in biomarker discovery and CAR T therapy using high-plex RNA

Engineering T‐Cells for Cancer Therapy: Challenges and Opportunities

Keynote - Cancer Immunology (Carl H. June)

Icahn School of Medicine

Engineered T Cell with CARs and TCRs for Hematologic Malignancy

CAR T-cells and CRISPR: The future of AML treatment

VJHemOnc – Video Journal of Hematology & HemOnc

CTSI Distinguished Speaker Series | E. John Wherry, U Penn

Genomic profile availability impact on NSCLC patient outcomes in real world study and daily practice

Smart T Cell Vaccines: CAR T Cells - by Carl June, MD

The Society for Translational Oncology

Gary Kohanbash Discusses Brain Tumor Immunotherapy on Fridays with Friedlander

University of Pittsburgh Neurosurgery

Science Spotlight - CAR T Cells: On the Road to Synthetic Immunity | Memorial Sloan Kettering

Memorial Sloan Kettering Cancer Center